Comparing alcohol treatment in Black churches and specialty clinics
Addressing Health Disparities by Providing Evidence-Based Treatment in the Black Church
NA · NYU Langone Health · NCT04580810
This study is testing a new way to help Black adults with alcohol problems by offering treatment in churches instead of regular clinics to see if it helps them start and stick with their recovery better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 132 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | NYU Langone Health (other) |
| Locations | 3 sites (New Haven, Connecticut and 2 other locations) |
| Trial ID | NCT04580810 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of a novel treatment strategy, CBT4CBT, delivered in Black churches versus traditional outpatient specialty addiction treatment for Black adults with Alcohol Use Disorder (AUD). The study will assess treatment initiation, engagement, and alcohol outcomes over multiple follow-up periods. By leveraging the trusted status of churches in the community, the trial seeks to engage individuals who may not otherwise seek treatment. The study will also evaluate the relative costs of this innovative treatment delivery method.
Who should consider this trial
Good fit: Ideal candidates are Black adults aged 18 and older with a current diagnosis of Alcohol Use Disorder.
Not a fit: Patients with active suicidal or homicidal ideation, unstable psychotic disorders, or those currently engaged in substance use treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve treatment initiation and retention rates for Black adults with AUD, leading to better recovery outcomes.
How similar studies have performed: Other studies have shown promise in using community-based settings for addiction treatment, suggesting potential success for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 18 years of age * current AUD as their principal substance use disorder, confirmed via MINI100 interview, with some drinking in the past 28 days * English-speaking Exclusion Criteria: * inability to provide informed consent or participate in the study procedures as proposed in the consent * active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder), * current engagement in substance use treatment, and * an unwillingness to be randomized to either condition. Individuals with comorbid substance use disorders will be included, as multiple substances of use are common in this population.
Where this trial is running
New Haven, Connecticut and 2 other locations
- Beulah Heights First Pentecostal Church — New Haven, Connecticut, United States (RECRUITING)
- Dixwell Ave Congregational United Church of Christ — New Haven, Connecticut, United States (RECRUITING)
- The Substance Abuse Training Unit (SATU) — New Haven, Connecticut, United States (RECRUITING)
Study contacts
- Principal investigator: Ayana Jordan, MD, PhD. — NYU Langone Health
- Study coordinator: Traci Norman
- Email: Traci.Norman@nyulangone.org
- Phone: 203-833-4267
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Alcohol Use Disorder